tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SCPH Stock Latest News

scPharmaceuticals’ Earnings Call Highlights Growth and Challenges
Company AnnouncementsscPharmaceuticals’ Earnings Call Highlights Growth and Challenges
14d ago
SCPH
Optimistic Buy Rating for scPharmaceuticals Amid Strong Q4 Results and Promising Developments
PremiumRatings
Optimistic Buy Rating for scPharmaceuticals Amid Strong Q4 Results and Promising Developments
14d ago
SCPH
scPharmaceuticals price target lowered to $12 from $20 at Maxim
PremiumThe Fly
scPharmaceuticals price target lowered to $12 from $20 at Maxim
15d ago
SCPH
Promising Growth Trajectory and Strategic Expansion Drive Buy Rating for scPharmaceuticals
PremiumRatings
Promising Growth Trajectory and Strategic Expansion Drive Buy Rating for scPharmaceuticals
15d ago
SCPH
Strong Growth Prospects for scPharmaceuticals: Buy Rating Justified by Furoscix Success and Strategic Expansion
PremiumRatings
Strong Growth Prospects for scPharmaceuticals: Buy Rating Justified by Furoscix Success and Strategic Expansion
16d ago
SCPH
scPharmaceuticals Reports Strong Revenue Growth in 2024
PremiumCompany AnnouncementsscPharmaceuticals Reports Strong Revenue Growth in 2024
16d ago
SCPH
scPharmaceuticals reports Q 4EPS (35c), consensus (39c)
Premium
The Fly
scPharmaceuticals reports Q 4EPS (35c), consensus (39c)
16d ago
SCPH
Options Volatility and Implied Earnings Moves Today, March 19, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 19, 2025
16d ago
KC
YY
Expanding Horizons: scPharmaceuticals’ Furoscix Gains FDA Approval for CKD, Broadening Market Potential
PremiumRatings
Expanding Horizons: scPharmaceuticals’ Furoscix Gains FDA Approval for CKD, Broadening Market Potential
24d ago
SCPH
Strategic Market Expansion and Strong Sales Foundation Drive Buy Rating for scPharmaceuticals
PremiumRatings
Strategic Market Expansion and Strong Sales Foundation Drive Buy Rating for scPharmaceuticals
28d ago
SCPH
scPharmaceuticals announces FDA approval of Furoscix indication expansion
PremiumThe Fly
scPharmaceuticals announces FDA approval of Furoscix indication expansion
29d ago
SCPH
Promising Outlook for scPharmaceuticals: Buy Rating Justified by Strong Demand and Strategic Initiatives
PremiumRatings
Promising Outlook for scPharmaceuticals: Buy Rating Justified by Strong Demand and Strategic Initiatives
1M ago
SCPH
scPharmaceuticals reports preliminary Q4 FUROSCIX revenue $12M-$12.3M
PremiumThe FlyscPharmaceuticals reports preliminary Q4 FUROSCIX revenue $12M-$12.3M
3M ago
SCPH
scPharmaceuticals price target lowered to $12 from $16 at Craig-Hallum
Premium
The Fly
scPharmaceuticals price target lowered to $12 from $16 at Craig-Hallum
5M ago
SCPH
scPharmaceuticals Reports Strong Growth in Q3 2024
Premium
Company Announcements
scPharmaceuticals Reports Strong Growth in Q3 2024
5M ago
SCPH
scPharmaceuticals reports Q3 EPS (41c), consensus (30c)
PremiumThe Fly
scPharmaceuticals reports Q3 EPS (41c), consensus (30c)
5M ago
SCPH
SCPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
SCPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
SCPH
scPharmaceuticals to host KOL webinar on FUROSCIX use
PremiumThe Fly
scPharmaceuticals to host KOL webinar on FUROSCIX use
6M ago
SCPH
scPharmaceuticals reports Q2 EPS (44c), consensus (41c)
PremiumThe Fly
scPharmaceuticals reports Q2 EPS (44c), consensus (41c)
8M ago
SCPH
scPharmaceuticals sells 12M shares at $4.00 in public offering
PremiumThe FlyscPharmaceuticals sells 12M shares at $4.00 in public offering
8M ago
SCPH
scPharmaceuticals Secures Funding, Advances FUROSCIX Commercialization
Premium
Company Announcements
scPharmaceuticals Secures Funding, Advances FUROSCIX Commercialization
8M ago
8K
SCPH
scPharmaceuticals reports $125M non-dilutive financings with Perceptive Advisors
Premium
The Fly
scPharmaceuticals reports $125M non-dilutive financings with Perceptive Advisors
8M ago
SCPH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >